Insider · CIK 0001725077

Bartushak Jaime

Reports to the SEC for 2 companies · CRANFORD, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001725077

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Chief Financial Officer	AAward	+825K sh	—	—	825,000
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Chief Financial Officer	AAward	+825K sh	—	—	825,000
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Chief Financial Officer	AAward	+825K sh	—	—	825,000
2024-12-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+400K sh	—	—	400,000
2024-11-07	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+350K sh	—	—	350,000
2024-08-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+1.4M sh	—	—	1,400,000
2024-08-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+467K sh	—	—	466,667
2023-10-10	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2022-10-04	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2021-10-11	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2021-07-22	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2020-10-06	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2019-10-08	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2018-09-04	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Chief Financial Officer	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Dec 224/A
Bartushak Jaime0001213900-25-124535
SEC(opens sec.gov)
Dec 14/A
Bartushak Jaime0001213900-25-116677
SEC(opens sec.gov)
Sep 234
Bartushak Jaime0001213900-25-090609
SEC(opens sec.gov)
Dec 164
Bartushak Jaime0001213900-24-109295
SEC(opens sec.gov)
Nov 124
Bartushak Jaime0001213900-24-096893
SEC(opens sec.gov)
Aug 304/A
Bartushak Jaime0001213900-24-074516
SEC(opens sec.gov)
Aug 144
Bartushak Jaime0001213900-24-069247
SEC(opens sec.gov)
Oct 124
Bartushak Jaime0001013762-23-003530
SEC(opens sec.gov)
Oct 64
Bartushak Jaime0001213900-22-062480
SEC(opens sec.gov)
Oct 134
Bartushak Jaime0001213900-21-052676
SEC(opens sec.gov)
Jul 264
Bartushak Jaime0001213900-21-038694
SEC(opens sec.gov)
Oct 94
Bartushak Jaime0001213900-20-030792
SEC(opens sec.gov)
Oct 104
Bartushak Jaime0001213900-19-020111
SEC(opens sec.gov)
Sep 64
Bartushak Jaime0001213900-18-012187
SEC(opens sec.gov)

Companies

Address

C/O CITIUS ONCOLOGY, INC. 11 COMMERCE DRIVE, 1ST FLOOR

CRANFORD, NJ, 07016